Identification and molecular biological mechanism study of subtypes caused by ABO*B.01 allele c. 3G>C mutation
Journal Title: Chinese Journal of Blood Transfusion - Year 2025, Vol 38, Issue 2
Abstract
[Objective] To study on the genotyping of a sample with inconsistent forward and reverse serological tests, and to conduct a pedigree investigation and molecular biological mechanism study. [Methods] The ABO blood group of the proband and his family members were identified using blood group serological method. The ABO gene exon 1-7 of samples of the proband and his family were sequenced by Sanger and single molecule real-time sequencing (SMRT). DeepTMHMM was used to predict and analyze the transmembrane region of proteins before and after mutation. [Results] The proband and his mother have the Bw phenotype, while his maternal grandfather has ABw phenotype. The blood group results of forward and reverse typing of other family members were consistent. ABO gene sequencing results showed that there was B new mutation of c.3 G>C in exon 1 of ABO gene in the proband, his mother and grandfather, leading to a shift in translation start site. DeepTMHMM analysis indicated that the shift in the translation start site altered the protein topology. [Conclusion] The c.3G>C mutation in the first exon of the ABO gene leads to a shift in the translation start site, altering the protein topology from an α-transmembrane region to a spherical signaling peptide, reducing enzyme activity and resulting in the Bw serological phenotype.
Authors and Affiliations
Yu ZHANG, Jie CAI, Yating LING, Lu ZHANG, Meng LI, Qiang FU, Chengtao HE
Keywords
Related Articles
- EP ID EP760115
- DOI 10.13303/j.cjbt.issn.1004-549x.2025.02.019
- Views 7
- Downloads 0
Correlation between the quantitative intensity of HLA-Ⅰ gene and its antibody and the clinical transfusion effect of matching platelets
Objective To explore the influence of anti-HLA-Ⅰ with different mean fluorescence intensity (MFI) on the efficacy of HLA-A and -B gene matching platelet transfusion, so as to provide scientific data for clinical platelet...
Characteristics of whole blood donors from 26 blood stations before and after the outbreak of COVID-19:a multicenter study
Objective To analyze the basic characteristics of whole blood donors from blood stations before and after the outbreak of COVID-19. Methods After excluding invalid data, data related to the basic characteristics of whole...
Thromboelastography and routine coagulation tests in the management of coagulation during ECMO therapy: a comparative study
Objective To investigate the correlation and consistency between the parameters of thromboelastography(TEG) and routine coagulation tests, and to evaluate the application value of the two methods in heparin anticoagulati...
A laboratory model for evaluating the risk of thrombosis in patients with chronic venous insufficiency
Objective To explore the predictive value of combined thromboelastography(TEG), coagulation index and platelet parameters in evaluating the risk of thrombosis in patients with chronic venous insufficiency(CVI). Methods A...
Application of ARIMA model in predicting pediatric red blood cell usage
Objective To explore the feasibility of using autoregressive moving average model (ARIMA) to predict the dosage of suspended red blood cells in children, and to provide a basis for the development of clinical blood reser...